Considerations for Adoption and Use of Multi-Disease Testing Devices in Integrated Laboratory Networks

 Originally published on June 27, 2019   Posted on June 27, 2019

Integrating testing using multiplex technologies at the appropriate level of care can lead to more efficient and cost-effective testing services and can help to simplify and streamline other systems, such as specimen referral, human resources, and quality assurance. Integration should be a priority for both those countries with currently operational multi-disease testing devices and those countries considering and planning for their introduction. This document, published by WHO in English, French and Portuguese, highlights issues related to: Government led coordinated planning; regulatory approval and validation; product and site selection; integrated specimen referral systems; SOPs and trainings for end users; capacity for supervision, monitoring and conducting trainings; demand generation; inventory management; quality management systems & data management and integration. It is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.